The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Leamon Christopher P since 2011.
The trader's CIK number is 1509415.
At the time of the last reporting, Leamon Christopher P was the Vice President of Research of Endocyte Inc. (stock ticker symbol ECYT).
Also see all insider trading activities at Endocyte Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | ECYT | 0 | $0 | 44,519 | $730,489 | 119,140 | $549,008 |
| 2017 | ECYT | 0 | $0 | 46,475 | $176,379 | 52,356 | $135,077 |
| 2015 | ECYT | 0 | $0 | 0 | $0 | 13,089 | $24,999 |
| 2013 | ECYT | 0 | $0 | 5,000 | $73,500 | 0 | $0 |
| 2012 | ECYT | 0 | $0 | 10,000 | $96,530 | 0 | $0 |
| 2011 | ECYT | 5,000 | $15,700 | 0 | $0 | 20,073 | $6,363 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-12-17 | ECYT | Option Ex | 101,774 | 4.96 | 504,900 |
| 2018-10-05 | ECYT | Sale | 9,028 | 15.56 | 140,439 |
| 2018-08-29 | ECYT | Sale | 4,696 | 20.00 | 93,920 |
| 2018-08-28 | ECYT | Option Ex | 12,670 | 2.54 | 32,181 |
| 2018-08-29 | ECYT | Option Ex | 4,696 | 2.54 | 11,927 |
| 2018-08-28 | ECYT | Sale | 12,670 | 20.00 | 253,400 |
| 2018-06-12 | ECYT | Sale | 13,089 | 15.05 | 197,054 |
| 2018-03-09 | ECYT | Sale | 5,036 | 9.07 | 45,676 |
| 2017-12-01 | ECYT | Option Ex | 26,178 | 3.06 | 80,104 |
| 2017-12-01 | ECYT | Sale | 23,231 | 5.04 | 117,107 |
| 2016-12-30 | ECYT | Option Ex | 26,178 | 2.10 | 54,973 |
| 2016-12-30 | ECYT | Sale | 23,244 | 2.55 | 59,272 |
| 2015-02-10 | ECYT | Option Ex | 13,089 | 1.91 | 24,999 |
| 2013-05-14 | ECYT | Sale | 5,000 | 14.70 | 73,500 |
| 2012-08-16 | ECYT | Sale | 10,000 | 9.65 | 96,530 |
| 2011-12-21 | ECYT | Buy | 5,000 | 3.14 | 15,700 |
| 2011-03-24 | ECYT | Option Ex | 20,073 | .32 | 6,363 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Leamon Christopher P (Vice President of Research of Endocyte Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.